Literature DB >> 22149958

Radiation dose associated with renal failure mortality: a potential pathway to partially explain increased cardiovascular disease mortality observed after whole-body irradiation.

Michael Jacob Adams1, Eric J Grant, Kazunori Kodama, Yukiko Shimizu, Fumiyoshi Kasagi, Akihiko Suyama, Ritsu Sakata, Masazumi Akahoshi.   

Abstract

Whole-body and thoracic ionizing radiation exposure are associated with increased cardiovascular disease (CVD) risk. In atomic bomb survivors, radiation dose is also associated with increased hypertension incidence, suggesting that radiation dose may be associated with chronic renal failure (CRF), thus explaining part of the mechanism for increased CVD. Multivariate Poisson regression was used to evaluate the association of radiation dose with various definitions of chronic kidney disease (CKD) mortality in the Life Span Study (LSS) of atomic bomb survivors. A secondary analysis was performed using a subsample for whom self-reported information on hypertension and diabetes, the two biggest risk factors for CRF, had been collected. We found a significant association between radiation dose and only our broadest definition of CRF among the full cohort. A quadratic dose excess relative risk model [ERR/Gy(2) = 0.091 (95% CI: 0.05, 0.198)] fit minimally better than a linear model. Within the subsample, association was also observed only with the broadest CRF definition [ERR/Gy(2) = 0.15 (95% CI: 0.02, 0.32)]. Adjustment for hypertension and diabetes improved model fit but did not substantially change the ERR/Gy(2) estimate, which was 0.17 (95% CI: 0.04, 0.35). We found a significant quadratic dose relationship between radiation dose and possible chronic renal disease mortality that is similar in shape to that observed between radiation and incidence of hypertension in this population. Our results suggest that renal dysfunction could be part of the mechanism causing increased CVD risk after whole-body irradiation, a hypothesis that deserves further study.

Entities:  

Mesh:

Year:  2011        PMID: 22149958      PMCID: PMC3413171          DOI: 10.1667/rr2746.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  29 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

3.  The effects of aging and radiation exposure on blood pressure levels of atomic bomb survivors.

Authors:  Hideo Sasaki; F Lennie Wong; Michiko Yamada; Kazunori Kodama
Journal:  J Clin Epidemiol       Date:  2002-10       Impact factor: 6.437

4.  A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer.

Authors:  Lawrence F Paszat; Katherine A Vallis; Veronique M A Benk; Patti A Groome; William J Mackillop; Andreas Wielgosz
Journal:  Radiother Oncol       Date:  2007-02-05       Impact factor: 6.280

5.  Cardiovascular diseases in the cohort of workers first employed at Mayak PA in 1948-1958.

Authors:  T V Azizova; C R Muirhead; M B Druzhinina; E S Grigoryeva; E V Vlasenko; M V Sumina; J A O'Hagan; W Zhang; R G E Haylock; N Hunter
Journal:  Radiat Res       Date:  2010-08       Impact factor: 2.841

6.  Induction of severe cataract and late renal dysfunction following total body irradiation: dose-effect relationships.

Authors:  Henk B Kal; M Loes VAN Kempen-Harteveld
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

7.  The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience.

Authors:  C K Lee; D Aeppli; M E Nierengarten
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

Review 8.  Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms.

Authors:  M P Little; E J Tawn; I Tzoulaki; R Wakeford; G Hildebrandt; F Paris; S Tapio; P Elliott
Journal:  Radiat Environ Biophys       Date:  2009-10-28       Impact factor: 1.925

Review 9.  Long-lasting alterations of the immune system by ionizing radiation exposure: implications for disease development among atomic bomb survivors.

Authors:  Yoichiro Kusunoki; Tomonori Hayashi
Journal:  Int J Radiat Biol       Date:  2008-01       Impact factor: 2.694

10.  Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003.

Authors:  Yukiko Shimizu; Kazunori Kodama; Nobuo Nishi; Fumiyoshi Kasagi; Akihiko Suyama; Midori Soda; Eric J Grant; Hiromi Sugiyama; Ritsu Sakata; Hiroko Moriwaki; Mikiko Hayashi; Manami Konda; Roy E Shore
Journal:  BMJ       Date:  2010-01-14
View more
  19 in total

Review 1.  Experimental radiation-induced heart disease: past, present, and future.

Authors:  Marjan Boerma
Journal:  Radiat Res       Date:  2012-06-04       Impact factor: 2.841

Review 2.  Space radiation and cardiovascular disease risk.

Authors:  Marjan Boerma; Gregory A Nelson; Vijayalakshmi Sridharan; Xiao-Wen Mao; Igor Koturbash; Martin Hauer-Jensen
Journal:  World J Cardiol       Date:  2015-12-26

3.  Circulatory disease mortality in the Massachusetts tuberculosis fluoroscopy cohort study.

Authors:  Mark P Little; Lydia B Zablotska; Alina V Brenner; Steven E Lipshultz
Journal:  Eur J Epidemiol       Date:  2015-08-09       Impact factor: 8.082

4.  Effects of single-dose protons or oxygen ions on function and structure of the cardiovascular system in male Long Evans rats.

Authors:  Vijayalakshmi Sridharan; John W Seawright; Reid D Landes; Maohua Cao; Preeti Singh; Catherine M Davis; Xiao-Wen Mao; Sharda P Singh; Xin Zhang; Gregory A Nelson; Marjan Boerma
Journal:  Life Sci Space Res (Amst)       Date:  2020-05-22

Review 5.  A review of non-cancer effects, especially circulatory and ocular diseases.

Authors:  Mark P Little
Journal:  Radiat Environ Biophys       Date:  2013-08-01       Impact factor: 1.925

6.  Cardiovascular effects after low-dose exposure and radiotherapy: what research is needed?

Authors:  Jan Wondergem; Marjan Boerma; Kazunori Kodama; Fiona A Stewart; Klaus R Trott
Journal:  Radiat Environ Biophys       Date:  2013-09-03       Impact factor: 1.925

7.  Delayed Effects of Acute Radiation Exposure in a Murine Model of the H-ARS: Multiple-Organ Injury Consequent to <10 Gy Total Body Irradiation.

Authors:  Joseph L Unthank; Steven J Miller; Ariel K Quickery; Ethan L Ferguson; Meijing Wang; Carol H Sampson; Hui Lin Chua; Matthew R DiStasi; Hailin Feng; Alexa Fisher; Barry P Katz; P Artur Plett; George E Sandusky; Rajendran Sellamuthu; Sasidhar Vemula; Eric P Cohen; Thomas J MacVittie; Christie M Orschell
Journal:  Health Phys       Date:  2015-11       Impact factor: 1.316

8.  A priming dose of protons alters the early cardiac cellular and molecular response to (56)Fe irradiation.

Authors:  Samy S Ramadan; Vijayalakshmi Sridharan; Igor Koturbash; Isabelle R Miousse; Martin Hauer-Jensen; Gregory A Nelson; Marjan Boerma
Journal:  Life Sci Space Res (Amst)       Date:  2015-12-14

9.  Cardiac injury after 10 gy total body irradiation: indirect role of effects on abdominal organs.

Authors:  Marek Lenarczyk; Vy Lam; Eric Jensen; Brian L Fish; Jidong Su; Stacy Koprowski; Richard A Komorowski; Leanne Harmann; Raymond Q Migrino; X Allen Li; John W Hopewell; John E Moulder; John E Baker
Journal:  Radiat Res       Date:  2013-08-06       Impact factor: 2.841

10.  Long-term results of total body irradiation in adults with acute lymphoblastic leukemia.

Authors:  Simone Marnitz; Alexander Zich; Peter Martus; Volker Budach; Ulrich Jahn; Oliver Neumann; Renate Arnold
Journal:  Strahlenther Onkol       Date:  2014-03-05       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.